Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
about
Antenatal corticosteroids for fetal lung maturation: an overview of Cochrane reviewsRisk-scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomesDifferent corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birthDifferent magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birthTransplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birthTransplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birthDifferent magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birthRisk scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomesRisk scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomesDifferent corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birthMagnesium sulphate for women at risk of preterm birth for neuroprotection of the fetusAntenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birthAntenatal corticosteroids to accelerate fetal lung maturation for women at risk of preterm birthAntenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Risk Factor Models for Neurodevelopmental Outcomes in Children Born Very Preterm or With Very Low Birth Weight: A Systematic Review of Methodology and Reporting.How old are you? Newborn gestational age discriminates neonatal resuscitation practices in the Italian debate.Survival and major neurodevelopmental impairment in extremely low gestational age newborns born 1990-2000: a retrospective cohort study.Prediction of mortality in very premature infants: a systematic review of prediction modelsAntenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008.Perinatal factors and regional brain volume abnormalities at term in a cohort of extremely low birth weight infantsContribution of brain size to IQ and educational underperformance in extremely preterm adolescents.Working to improve survival and health for babies born very preterm: the WISH project protocol.Neural correlates of impaired vision in adolescents born extremely preterm and/or extremely low birthweight.Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity.Developmental and neuropathological consequences of ductal ligation in the preterm baboon.Survival and major disability rate in infant born at 22-25 weeks of gestation.Cardiovascular instability after patent ductus arteriosus ligation in preterm infants: the role of hydrocortisone.Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants.Developmental Screening Among Children Born Preterm in a High-Risk Follow-Up Clinic.What are we telling the parents of extremely preterm babies?Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013.The long-term outcome of extremely preterm (<28 weeks' gestational age) infants with and without severe retinopathy of prematurity.Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort.Survival and neurodevelopmental outcome of ELBW children at 5 years of age: comparison of two cohorts born 10 years apart.Visual memory and learning in extremely low-birth-weight/extremely preterm adolescents compared with controls: a geographic study.Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand.Atypical auditory event-related potentials in preterm infants during the first year of life: a possible sign of cognitive dysfunction?Parent-reported health in extremely preterm and extremely low-birthweight children at age 8 years compared with comparison children born at term.Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
P2860
Q24185978-D1F83EA1-70CB-4E0A-9DEA-39641AB83FBDQ24186421-B3B87DB1-571D-45C3-B8FF-9CF41B4982A3Q24200191-491F36BF-B349-441A-A8D9-067B16D95844Q24203697-74B1EFA9-1F3E-4278-91B1-7EA585ACCC5DQ24234298-B84AD4D3-9033-461D-B9E3-21DA833644A9Q24234322-65776FB8-B6BE-4EF4-A906-CB9E4A76D76BQ24234738-72EE0AA9-959B-45AD-A9FC-0B9382A09E20Q24235378-93EB00D4-CBB4-47F6-8F06-1A65859C5EFCQ24235670-E7F3906D-5173-43D1-8A0B-905AB89B13FBQ24241266-48573667-CFBE-4AD5-AFA0-EA82E2E6E952Q24241616-502E4440-23F0-457C-81A9-97A62291FA9AQ24245169-0572A282-D12D-4120-94EC-5A7240A3A935Q24247837-5BA558B3-8D0F-4AEE-998A-975E3CC20CF9Q30400140-EF465990-FBA6-4200-BC09-3024CC554291Q30400283-65B0242B-73AB-4739-B91A-64098CF47F8AQ30883639-75D201F1-BC59-47C1-9A6D-8678D48935BBQ33283631-3632C6A9-8862-4DC3-95D4-224442C98262Q34023097-47DD1FBF-0DBF-4307-9A1E-8C08745CDF89Q34269738-19DC341D-0BAE-42DD-AA45-21B5DC050C6AQ34526515-A6636A3A-0FD8-400D-8315-D4BAB819C750Q34720825-E688F63D-1E70-4BA5-A0FA-0B123DECBCBFQ35018877-A43BB2B2-AAA9-494E-B3C0-07A67B9A8B38Q35071956-89D304EF-CE26-4F11-B491-5DDBBE8B658AQ35129116-37D974FB-3BDC-4019-955F-BE4EDCA43C14Q35762455-43694B11-DED1-4F3C-804E-2E2F32F9BD4CQ37201776-CF665175-4DEC-4D12-9920-5E8796A8B90BQ37547238-077E2C7A-9151-4314-8AD6-A9C26A8E1B36Q37957598-E579E6F2-C3FF-41A0-A322-9F9580B27AE3Q37976955-1CE35DC9-0FCB-4C85-83D0-803DF71844B1Q38626538-E81563D5-D043-47C3-BEB1-395C843D2F09Q39968903-9F34DFAF-2693-49A0-AA8D-1A0518DA4800Q40826839-982AD71D-0AAF-4545-8468-51A0E06EF934Q41159625-AB6132FA-7F15-49B1-8C87-F1F4E518A645Q41276290-D9C2A693-AD51-4502-B8DB-F4DFBAABF4BAQ43720013-B494828D-876F-41FE-859B-A5AB245DEA4DQ43741673-F569127F-2C19-4D03-950B-57933140E862Q44670169-7F29E6C8-14CB-4BA4-B01E-1B720F659FC0Q44924461-1BE692FC-52F8-4913-AB61-CF037C7AAF28Q45045779-C081695E-6B5F-4704-8458-A39141A5BF11Q46008896-5BFE0E80-F104-44DE-B907-A4FC1B85D1BB
P2860
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
description
im Juli 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 July 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2001
@uk
name
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
@en
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
@nl
type
label
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
@en
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
@nl
prefLabel
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
@en
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
@nl
P356
P1433
P1476
Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis
@en
P2093
Victorian Infant Collaborative Study Group
P304
P356
10.1542/PEDS.108.1.134
P407
P50
P577
2001-07-01T00:00:00Z